S Hsu, MD
Hematology · Visalia, CANPI 1912971300
Payments from drug & device makers
Across 96 payments — averaging $28.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$391
- Incyte Corporation$301
- Amgen$288
- Sanofi$238
- Gilead$151
- Genentech USA, Inc.$135
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,732100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 12 | $391 |
| Incyte Corporation | 7 | $301 |
| Amgen | 7 | $288 |
| Sanofi | 7 | $238 |
| Gilead | 2 | $151 |
| Genentech USA, Inc. | 2 | $135 |
| Daiichi Sankyo Inc. | 4 | $89 |
| Merck | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Novartis | 4 | $77 |
| Exelixis Inc. | 1 | $76 |
| Sobi, Inc | 3 | $72 |
| Johnson & Johnson | 4 | $64 |
| Bayer | 4 | $56 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Astellas Pharma US Inc | 2 | $45 |
| Apellis Pharmaceuticals, Inc. | 2 | $44 |
| Morphosys, US Inc. | 2 | $43 |
| Deciphera Pharmaceuticals Inc. | 2 | $37 |
| Array Biopharma Inc | 2 | $37 |
| Tesaro, Inc. | 2 | $36 |
| Octapharma USA, Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $29 |
| Dendreon Pharmaceuticals LLC | 1 | $25 |
| Seagen Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $24 |
| AVEO Pharmaceuticals, Inc. | 1 | $22 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Pharmaessentia USA Corporation | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| Taiho Oncology, Inc. | 1 | $16 |
| BTG International Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,732 in reported general payments places this provider in the 35th percentile of 178 hematology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Visalia
- Tait ShanafeltStanford$441.4M
- Alex HerreraDuarte$50.9M
- Hope RugoSan Francisco$23.8M
- Tycel PhillipsDuarte$21.6M
- Lihua BuddeDuarte$21.5M
- Tanya SiddiqiDuarte$18.8M
- Amrita KrishnanDuarte$14M
- Anthony SteinDuarte$12.1M
- Alexey DanilovDuarte$11.3M
- Vincent ChungDuarte$11.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.